238 related articles for article (PubMed ID: 19968833)
21. Bromocriptine in polycystic ovarian disease: a controlled clinical trial.
el Tabbakh GH; Loutfi IA; Azab I; Rahman HA; Southren AL; Aleem FA
Obstet Gynecol; 1988 Mar; 71(3 Pt 1):301-6. PubMed ID: 3279350
[TBL] [Abstract][Full Text] [Related]
22. Relationship between prolactin levels and subjective endocrine-related adverse effects in patients with schizophrenia receiving long-term treatment with amisulpride.
Kim EY; Kim SH; Lee NY; Jung DC; Kim YS; Ahn YM
Pharmacopsychiatry; 2012 Mar; 45(2):57-63. PubMed ID: 22411694
[TBL] [Abstract][Full Text] [Related]
23. Effects of the antipsychotic drug sulpiride on reproductive hormones in healthy premenopausal women: relationship with body weight regulation.
Baptista T; Molina MG; Martinez JL; de Quijada M; Calanche de Cuesta I; Acosta A; Páez X; Martinez JM; Hernández L
Pharmacopsychiatry; 1997 Nov; 30(6):256-62. PubMed ID: 9442548
[TBL] [Abstract][Full Text] [Related]
24. Clinical and hormonal response to short-term intermittent versus continuous oral bromocriptine in hyperprolactinemic women.
Parra A; Crespo G; Coria I; Espinosa de los Monteros A
Int J Fertil Menopausal Stud; 1995; 40(2):96-101. PubMed ID: 7599666
[TBL] [Abstract][Full Text] [Related]
25. Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study.
Wu RR; Jin H; Gao K; Twamley EW; Ou JJ; Shao P; Wang J; Guo XF; Davis JM; Chan PK; Zhao JP
Am J Psychiatry; 2012 Aug; 169(8):813-21. PubMed ID: 22711171
[TBL] [Abstract][Full Text] [Related]
26. Attenuation of antipsychotic-induced hyperprolactinemia with clozapine.
Bunker MT; Marken PA; Schneiderhan ME; Ruehter VL
J Child Adolesc Psychopharmacol; 1997; 7(1):65-9. PubMed ID: 9192542
[TBL] [Abstract][Full Text] [Related]
27. Effects of bromocriptine on neuroleptic-induced amenorrhea, galactorrhea and impotence.
Matsuoka I; Nakai T; Miyake M; Hirai M; Ikawa G
Jpn J Psychiatry Neurol; 1986 Dec; 40(4):639-46. PubMed ID: 2885437
[TBL] [Abstract][Full Text] [Related]
28. Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics.
Chen CK; Huang YS; Ree SC; Hsiao CC
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1495-9. PubMed ID: 20732372
[TBL] [Abstract][Full Text] [Related]
29. Olanzapine-induced hyperprolactinemia and galactorrhea reversed with addition of bromocriptine: a case report.
Miller DE; Sebastian CS
J Clin Psychiatry; 2005 Feb; 66(2):269-70. PubMed ID: 15705020
[No Abstract] [Full Text] [Related]
30. Effect of bromocriptine on affect and libido in hyperprolactinemia.
Koppelman MC; Parry BL; Hamilton JA; Alagna SW; Loriaux DL
Am J Psychiatry; 1987 Aug; 144(8):1037-41. PubMed ID: 3300375
[TBL] [Abstract][Full Text] [Related]
31. Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: a pilot study.
Lee BH; Kim YK; Park SH
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):714-7. PubMed ID: 16571367
[TBL] [Abstract][Full Text] [Related]
32. Triiodothyronine may be possibly associated with better cognitive function and less extrapyramidal symptoms in chronic schizophrenia.
Ichioka S; Terao T; Hoaki N; Matsushita T; Hoaki T
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):170-4. PubMed ID: 22750309
[TBL] [Abstract][Full Text] [Related]
33. Blonanserin, a novel antipsychotic, is suitable for treating schizophrenia associated with hyperprolactinemia: a case series.
Kawabe K; Horiuchi F; Ueno S
Clin Neuropharmacol; 2013; 36(6):239-41. PubMed ID: 24201238
[TBL] [Abstract][Full Text] [Related]
34. Bromocriptine for infertile males with mild hyperprolactinemia: hormonal and spermatogenic effects.
Nishimura K; Matsumiya K; Tsuboniwa N; Yamanaka M; Koga M; Miura H; Tsujimura A; Uchida K; Kondoh N; Kitamura M; Okuyama A
Arch Androl; 1999; 43(3):207-13. PubMed ID: 10624504
[TBL] [Abstract][Full Text] [Related]
35. Antipsychotic-induced hyperprolactinemia inhibits the hypothalamo-pituitary-gonadal axis and reduces bone mineral density in male patients with schizophrenia.
Kishimoto T; Watanabe K; Shimada N; Makita K; Yagi G; Kashima H
J Clin Psychiatry; 2008 Mar; 69(3):385-91. PubMed ID: 18278991
[TBL] [Abstract][Full Text] [Related]
36. Impact of a switch from typical to atypical antipsychotic drugs on quality of life and gonadal hormones in male patients with schizophrenia.
Kaneda Y; Kawamura I; Fujii A; Ohmori T
Neuro Endocrinol Lett; 2004; 25(1-2):135-40. PubMed ID: 15159697
[TBL] [Abstract][Full Text] [Related]
37. Adjunctive Aripiprazole Treatment for Risperidone-Induced Hyperprolactinemia: An 8-Week Randomized, Open-Label, Comparative Clinical Trial.
Zhao J; Song X; Ai X; Gu X; Huang G; Li X; Pang L; Ding M; Ding S; Lv L
PLoS One; 2015; 10(10):e0139717. PubMed ID: 26448615
[TBL] [Abstract][Full Text] [Related]
38. The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis.
Smith S; Wheeler MJ; Murray R; O'Keane V
J Clin Psychopharmacol; 2002 Apr; 22(2):109-14. PubMed ID: 11910254
[TBL] [Abstract][Full Text] [Related]
39. [Efficacy of compound xuanju capsule combined with bromocriptine on hyperprolactinemia-induced erectile dysfunction].
Bian J; Liu CD; Sun XZ; Deng CH; Huang YP; Ye YL
Zhonghua Nan Ke Xue; 2012 Nov; 18(11):1023-7. PubMed ID: 23214255
[TBL] [Abstract][Full Text] [Related]
40. Impact of risperidone medication on quality of life and gonadal axis hormones in schizophrenia male patients with acute exacerbation.
Kaneda Y; Ohmori T
Int J Neuropsychopharmacol; 2003 Sep; 6(3):247-52. PubMed ID: 12974991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
